Thus, the modest obesity-induced pro-inflammatory milieu, involving small increases in systemic IL-6, are unlikely to impact the local IL-6 concentrations and accelerate inflammation-driven cancer progression. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.